Ignite Creation Date:
2025-12-25 @ 4:53 AM
Ignite Modification Date:
2026-02-22 @ 7:49 PM
Study NCT ID:
NCT02961218
Status:
COMPLETED
Last Update Posted:
2021-10-11
First Post:
2016-10-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Pediatric and Young Adult Patients With Sickle Cell Anemia
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-04-05
Start Date Type:
ACTUAL
Primary Completion Date:
2019-06-27
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-04-27
Completion Date Type:
ACTUAL
First Submit Date:
2016-10-20
First Submit QC Date:
None
Study First Post Date:
2016-11-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-10-27
Results First Submit QC Date:
None
Results First Post Date:
2020-12-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2020-12-17
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-10-07
Last Update Post Date:
2021-10-11
Last Update Post Date Type:
ACTUAL